awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33903078-4F283C1A-DB5D-4CB3-AC12-A8C323D3EE8A
Q33903078-4F283C1A-DB5D-4CB3-AC12-A8C323D3EE8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33903078-4F283C1A-DB5D-4CB3-AC12-A8C323D3EE8A
Randomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904.
P2860
Q33903078-4F283C1A-DB5D-4CB3-AC12-A8C323D3EE8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33903078-4F283C1A-DB5D-4CB3-AC12-A8C323D3EE8A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
570d75c18b13f80e2b566114ea11af93905361ac
P2860
Vandetanib plus pemetrexed for the second-line treatment of advanced non-small-cell lung cancer: a randomized, double-blind phase III trial.